Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Other Working Capital Changes (2020 - 2025)

Historic Other Working Capital Changes for IceCure Medical (ICCM) over the last 6 years, with Q3 2025 value amounting to $456000.0.

  • IceCure Medical's Other Working Capital Changes rose 132500.0% to $456000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$188000.0, marking a year-over-year decrease of 13241.38%. This contributed to the annual value of -$237000.0 for FY2024, which is 14778.23% down from last year.
  • Per IceCure Medical's latest filing, its Other Working Capital Changes stood at $456000.0 for Q3 2025, which was up 132500.0% from -$121000.0 recorded in Q2 2025.
  • In the past 5 years, IceCure Medical's Other Working Capital Changes ranged from a high of $2.3 million in Q4 2021 and a low of -$1.2 million during Q4 2022
  • Moreover, its 5-year median value for Other Working Capital Changes was $32000.0 (2024), whereas its average is $78421.1.
  • The largest annual percentage gain for IceCure Medical's Other Working Capital Changes in the last 5 years was 132500.0% (2025), contrasted with its biggest fall of 26153.85% (2025).
  • Over the past 5 years, IceCure Medical's Other Working Capital Changes (Quarter) stood at $2.3 million in 2021, then tumbled by 153.58% to -$1.2 million in 2022, then skyrocketed by 131.16% to $378000.0 in 2023, then crashed by 216.14% to -$439000.0 in 2024, then soared by 203.87% to $456000.0 in 2025.
  • Its Other Working Capital Changes was $456000.0 in Q3 2025, compared to -$121000.0 in Q2 2025 and -$84000.0 in Q1 2025.